EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended‐Release Tacrolimus (LCPT) Using Grapefruit Juice

Adekunle Alabi, Janice S Kerr, Mita Shah, Adnan Khan, Joseph D Ma, Raymond T Suhandynata, Jeremiah D Momper, Shirley M Tsunoda

Clinical Pharmacology in Drug Development · 2026-01 · 15 (1)

DOI: 10.1002/cpdd.70016 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology in Drug Development, online erschienen am 19.01.2026. Verfasst von Adekunle Alabi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Hauptthemen laut MEDLINE: Tacrolimus, Citrus paradisi, Cytochrome P-450 CYP3A, Food-Drug Interactions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Veloxis Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Grapefruit juice (GFJ) is a known inhibitor of intestinal cytochrome P450 3A (CYP3A) metabolism leading to increased exposure to CYP3A substrates such as tacrolimus. The extended‐release tacrolimus formulation Envarsus (LCPT) exhibits prolonged absorption throughout the entire GI tract. Although a clinically significant drug–drug interaction occurs with immediate‐release tacrolimus formulations, this has not been evaluated with extended‐release formulations. This study assessed the impact of GFJ on LCPT in adult kidney transplant patients. Eleven adult kidney transplant recipients on a stable dose of LCPT were enrolled in a randomized crossover study. Participants were administered either GFJ or water during each pharmacokinetic visit, with midazolam used as a positive control. A washout period of 2–4 weeks was included between visits. Tacrolimus concentrations were determined using validated LC‐MS/MS methods. Tacrolimus AUC 0–24 was 28% higher with GFJ (GMR = 1.28, 90% CI 1.12–1.44) and C max was 73% higher (GMR = 1.73, 90% CI 1.46–2.00) compared to control. GFJ exhibited a clinically meaningful interaction with LCPT. However, the magnitude appears less than those reported with immediate‐release formulations, suggesting the extended absorption profile of LCPT may affect susceptibility to drug interactions in the intestine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusCitrus paradisiCytochrome P-450 CYP3AFood-Drug InteractionsFruit and Vegetable JuicesImmunosuppressive AgentsCytochrome P-450 CYP3A InhibitorsHumansMaleCross-Over StudiesFemaleMiddle AgedAdultDelayed-Action PreparationsArea Under CurveKidney TransplantationMidazolamDrug Interactions

Stichwörter der Autor:innen

EnvarsusLC‐MS/MScytochrome P450 3Adrug–drug interactionsgrapefruit juicemidazolamtacrolimus

Substanzen

TacrolimusCytochrome P-450 CYP3ADelayed-Action PreparationsImmunosuppressive AgentsCYP3A protein, humanCytochrome P-450 CYP3A InhibitorsMidazolam

Autor:innen und Institutionen

  • Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Department of Pharmacy, UC San Diego Health, San Diego, CA, USA.
  • Department of Medicine, UC San Diego Health, San Diego, CA, USA.
  • Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, La Jolla, CA, USA.

Förderung

  • Veloxis Pharmaceuticals

Zitieren

APA

Alabi, A., Kerr, J. S., Shah, M., Khan, A., Ma, J. D., Suhandynata, R. T., Momper, J. D., & Tsunoda, S. M. (2026). Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended‐Release Tacrolimus (LCPT) Using Grapefruit Juice. Clinical Pharmacology in Drug Development, 15(1). https://doi.org/10.1002/cpdd.70016

Vancouver

Alabi A, Kerr JS, Shah M, Khan A, Ma JD, Suhandynata RT, et al. Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended‐Release Tacrolimus (LCPT) Using Grapefruit Juice. Clinical Pharmacology in Drug Development. 2026;15(1). doi:10.1002/cpdd.70016

BibTeX
@article{Alabi2026,
  author = {Alabi, Adekunle and Kerr, Janice S and Shah, Mita and Khan, Adnan and Ma, Joseph D and Suhandynata, Raymond T and Momper, Jeremiah D and Tsunoda, Shirley M},
  title = {Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended‐Release Tacrolimus (LCPT) Using Grapefruit Juice},
  journal = {Clinical Pharmacology in Drug Development},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1002/cpdd.70016}
}
Kostenlos starten →